Disease | headache |
Phenotype | C0042373|vascular diseases |
Sentences | 1 |
PubMedID- 23890176 | Yxqn (tianjin tasly pharmaceutical co. ltd., tianjin, china) is a newly developed compound medicine that was approved in 1996 by the china state food and drug administration for the treatment of headache and dizziness associated with cerebrovascular diseases. |
Page: 1